' & $ % Synopsis NRG1 (neuregulin 1) belongs to the NRG family of EGF (epidermal growth factor)-like signalling molecules involved in cell-cell communication during development and disease. It plays important roles in the developing tissues of the nerves, heart and mammary glands. Particularly in neurobiology, NRG1 signalling is associated with synaptic transmission, myelination of Schwann cells and the human disease of schizophrenia. Many different isoforms of NRG1 make the molecule highly sophisticated in biological activities and a great diversity of in vivo functions. The nervous system is a common trait in all bilateria (higher animals), but based on the BLAST information from the currently available databases it appears that NRG1 orthologues can only be identified in vertebrates. The gene was analysed in silico for type I-IV CDSs (coding sequences) from ten vertebrate genomes. The gene loci, structures of codingintronic sequences, ClustalW program analyses, phylogenetic trees and conserved motifs in ecto-and cyto-plasmic domains were analysed and compared. Here, we conclude that non-mammalian vertebrates mainly carry type I (may have evolved a spacer different from mammalian isoforms), II and III NRG1s. The type IV NRG1 N-terminal CDSs can be identified from most of the mammalian genomes studied; however, the corresponding rodent sequences lack the start codon. The evolutionary conservation of a CDS 59 -CDS 24 -CDS 103 domain, intracellular phosphorylation sites and bipartite nuclear localization signals is of physiological significance.
INTRODUCTION
NRG1s (neuregulins 1), a family of growth and differentiation factors, are ligands [EGF (epidermal growth factor)-like domains correspondingly] for the ERBB family of receptor tyrosine kinases and play multiple roles in the development and function of different organs including the nervous system. Other than the most essential EGF-like domains (α, β and γ variants mainly), NRG1s are composed of N-terminal [including Kringle-like (type II) and cysteine-rich TM (transmembrane) (type III)], Ig-like, spacer, stalk (juxtamembrane), TM, cytoplasmic and tail (a, b or c) domains. Mouse lines produced by domain-specific gene disruption for Ig-like [1] , EGF-like [2] , TM [3] or cytoplasmic [4] domains of Nrg1 resulted in the death of all homozygous mutants at E10.5-11.5 (embryonic days 10.5-11.5) owing to circulatory failure and exhibited defects in neural and cardiac development, whereas heterozygous mice are viable and fertile. NRGs also Abbreviations used: BACE1, β-site amyloid precursor protein-cleaving enzyme 1; CDS, coding sequence; EGF, epidermal growth factor; EQ, encephalization quotient; GGF2, glial growth factor-2; N-CDS, N-terminal CDS; NLS, nuclear localization signal; PKC, protein kinase C; RefSeq, Reference Sequence; RT-PCR, reverse transcription-PCR; NRG, neuregulin; sNRG1, soluble NRG1, TACE, TNFα (tumour necrosis factor α)-converting enzyme; TM, transmembrane; Vn protein, Vein protein. 1 Correspondence may be addressed to either of these authors (email chouchihfong@yahoo.com or mozaki@waseda.jp).
play critical roles in both proliferative and antiproliferative effects according to the study of the progression of breast cancer [5] . Inappropriate NRG1 signalling has severe consequences not only in cancer pathology, but also in neurological and psychiatric disorders including multiple sclerosis, schizophrenia and Alzheimer's disease [6] . Consequently, NRG1 has empirically been proposed to regulate genes encoding certain neurotransmitter receptors during synapse formation as well as functions [7] . Furthermore, homozygous mutants of mouse type III neuronspecific Nrg1 die at postnatal day 0 and lead to widespread failure to maintain peripheral synapses [8] , degeneration of sensory and motor neurons [9] and defective neuronal and axonal migration in the telencephalon [10] .
NRG1s are involved in mediating bidirectional signalling through at least five possible mechanisms: three in the outward direction via the interaction with their cognate receptors (different dimerized combinations of ERBB 2−4 ) to elicit signals by kinase activity plus two inward signalling mechanisms. The extracellular domains of NRG1s act both as juxtacrine (direct cell-cell contact) signalling proteins [11] and as diffusible (proteolytically released or expressed soluble isoforms) paracrine signalling molecules to interact with the receptor. Intracellularly, NRG1 isoforms expressed without the signal peptide and TM domain are soluble in the cytosol and targeted to the nucleolus [12] . Furthermore, the cytoplasmic domain of NRG1s interacts with LIM kinase 1 [13] that acts as a signal receptor; moreover, the free cytoplasmic domain cleaved from the inner juxtamembrane retains the NLS (nuclear localization signal) motif for the inward signalling [14] . This sophisticated protein has been identified in many vertebrates, and the differences between lower and higher vertebrates are of interest to be analysed.
The multifunctional NRG1 is encoded by a large and complex gene with 15-20 different isoforms, which are expressed from six promoters (types I-VI) coupled with alternatively spliced transcripts. Types I-III are encoded in a wide range of vertebrate genomes, and types V and VI appear to be restricted to primates. In the analyses presented in this study, we have mainly focused on the dominant type I isoforms. However, we also paid special attention to type IV NRG1, which has been demonstrated to be a unique brain-specific isoform and a disease (schizophrenia) associated polymorphism that alters promoter strength [15] . This isoform can be identified only in mammalian genomes, while the N-CDS [N-terminal CDS (coding sequence)] appears partially in rodent genomes.
MATERIALS AND METHODS

Identification of vertebrate NRG1 genes
The human full-length type I NRG1-β protein sequence [NCBI (National Center for Biotechnology Information) RefSeq (Reference Sequence) NP_039250.2] was used as a basic template to BLAST search against some mammalian databases (rhesus monkey, horse, cow, rat and mouse) on UCSC (University of California, Santa Cruz; CA, U.S.A.) Genome Bioinformatics (available online at http://genome.ucsc.edu/). For the BLAST search of type II-IV N-terminal coding regions, the following sequences were used: RefSeq NP_039256. 2 
Sequence analyses of ClustalW program alignments, phylogenies and motif predictions
The coding/intronic sequence organization of NRG1s was analysed from the BLAST results of matching cDNA sequences within the genomic DNAs based on consensus GT and AG sites of splice donor and acceptor sequences. The NRG1 loci were referenced from the UCSC Genome Browser for locating and comparing NRG1 neighbour genes. Alignments of the NRG1 protein sequences of all vertebrates were generated using the ClustalW program (service provided by the Swiss Institute of Bioinformatics at http://www.ch.embnet.org/software/ ClustalW.html). The phylogenetic analyses of NRG1 proteins and cDNA sequences were obtained using the TreeTop program (Phylogenetic Tree Prediction at http://www.genebee. msu.ru/services/phtree_reduced.html). The cytoplasmic phosphorylation sites and bipartite NLSs were identified by using the service at http://myhits.isb-sib.ch/cgi-bin/motif_scan [16] , and the glycosylation sites were predicted by using the CBS (Center for Biological Sequence Analysis) Prediction Servers (at http://www.cbs.dtu.dk/services/).
RESULTS
Gene structures of NRG1 and protein sequence alignments
To identify NRG1 CDSs from all of the studied genomes, we BLAST searched ten vertebrate genomes using human and rat NRG1 sequences, mainly for mammalian databases, and chicken, X. laevis and Danio sequences for non-mammalian databases. In Supplementary Table S1 (see http://www.bioscirep.org/ bsr/030/bsr0300267add.htm) of the supporting online material, the nucleotide numbers of each CDS and intron in the ten vertebrate NRG1s (types I-IV) are listed. The CDSs of mammalian NRG1s that are less diversified are categorized under the same column and exceptions are clarified in the footnotes. N-terminal coding regions of type I (lizard) and type II [chicken, lizard and frog (X. tropicalis)] NRG1s cannot be identified (UI) from the limited sequence data (lizard scaffold sequence) or ambiguous regions (horse, chicken and frog databases). Although type IV NRG1 was considered to be restricted to primates [17] , the N-CDS can be identified in horse and cow databases. The spacer of NRG1 encoded by CDS 51a and CDS 51b cannot be identified in non-mammalian genes, and CDSs for the b-and c-tails appear to be non-existent except for frog nrg1. The β3 variant of sNRG1 is conserved in all of the studied genes; however, the putative β3 isoforms of non-mammalian NRG1 are not annotated. Another sNRG1 isoform γ, which is also a product of alternative splicing that skips off of the splice site and generates a premature termination codon (indicated by an asterisk in Supplementary Figure S1) . A motif scan of the cytoplasmic domains identified conserved phosphorylation sites for PKC (protein kinase C), protein kinase CK2 and tyrosine kinase, suggesting possible mechanisms of NRG1 in signalling. All of the studied protein and cDNA sequences are listed in the supporting online material.
Conserved syntenic NRG1 loci and phylogenies
In order to prove that the sequences used in our analysis are orthologous, NRG1 with common neighbour genes [PPP2CB (protein phosphatase 2 catalytic subunit-β), TEX15 (testis expressed 15), PURG (purine-rich element binding protein G), WRN (Werner syndrome protein variant) and FUT10 (fucosyltransferase 10); A-E in Figure 1A ] in human, rat, mouse, cow, chicken, lizard, frog and zebrafish loci are shown to reveal the conserved synteny as well as orthology. LPL (F; in the chicken locus) and SH2D4A (G; in the frog locus) are located further upstream of the human locus (see Supplementary Figure S2 at http://www.bioscirep.org/bsr/030/bsr0300267add.htm). The lizard NRG1 sequence is confined to a relatively limited scaffold and there is lack of information about neighbour genes (the same as the loci of rhesus monkey and horse) to show the conservation. Primates, rodents, horse, cow, birds, reptiles, amphibians and teleosts are important vertebrate models that have evolved from the Osteichthyes (bony fishes) lineage. Here, the NRG1-β1a full-length protein sequences and CDSs (CDS 59(β) -CDS 24 -CDS 103 ) of ten vertebrates were analysed for phylogeny. The phylogenetic trees in Figure 1 Supplementary Table  S1 and Supplementary Figure S1) ; however, the cDNA clone of another amphibian X. laevis nrg1 [27] has been demonstrated to encode a longer spacer. Supplementary Figure S7 (see http://www.bioscirep.org/bsr/030/bsr0300267add.htm) presents the protein ClustalW program alignment between X. laevis nrg1-β1a and other non-mammalian sequences, where the spacer is underlined and in boldface. We then checked the location of the encoding spacer and found that the CDS is located at the 3 -end of type III N-CDS, and the corresponding putative spacer CDSs can be identified in other non-mammalian sequences (see Supplementary Table S1 , CDS 5) with similar splicing sites and without frameshift mutagenesis. ClustalW program alignments of the N-terminal domains of non-mammalian type III NRG1s ( Figure 3A) show significant conservation only in amphibians; however, higher degrees of conservation patterns can be revealed in separate alignments ( Figure 3B ). The spacer is known as the Nand O-linked glycosylated domain [28] in mammalian NRG1s; accordingly O-linked glycosylation sites could be predicted in non-mammalian spacers ( Figure 3C ). So far, X. laevis nrg1 is the only non-mammalian spacer that has been supported by sequencing data (GenBank ® accession number AAC26804.1).
Alignments of the highly conserved domain and the putative non-mammalian spacers
Type IV N-terminus of mammalian NRG1s
Brain-specific type IV NRG1 was known to be restricted to primates [17] ; however, the putative type IV N-CDSs could be identified in mammals other than primates. Both type II and IV N-CDSs are located far upstream of type I N-CDS in the mammalian genomes around 900 kb. In Figure 4 , the locations of predicted horse and cow type IV NRG1 N-CDSs are 
Figure 2 ClustalW analysis
ClustalW program analyses of the α variants (encoded by CDS 68 ) and the highly conserved domains encoded by CDS 59 -CDS 24 -CDS 103 (A). The conserved BACE1 cleavage site (indicated by an arrowhead) FM is in boldface and underlined; the bold, underlined and italic V is involved in the cleavage of γ-secretase. The first XXX indicates the border between the ecto and TM domains and the second XXX represents the border between TM and cytoplasmic domains. The underlined and italic threonine (T) is a putative PKC phosphorylation site conserved in all peptides. (B) EGF-like β3 domains encoded by CDS 130 (mammalian NRG1) plus the CDS of β variants (CDS 91 , alternated without splicing) and then followed by continuous translation to express sNRG1 with premature termination. In the alignments (peptide sequences from ten vertebrates for both A and B), identical amino acids are presented as upper-case letters, whereas non-identical residues are shown as lower-case, underlined (conserved substitutions) and bold (non-conserved substitutions) letters. CD, CDS.
presented; the distances between cow type IV-II N-CDSs as well as the intron sizes (type IV N-CDS to the second exon CDS 178 ) are similar to primates (see Supplementary Table S1 ). Interestingly, the genomic sequences around human type IV and II N-CDSs are highly conserved not only in primates, but also in rodent (see Supplementary Figure S8 
DISCUSSION
In Supplementary Table S1 , the N-CDS prediction of lizard type I NRG1 is limited by the available data of the genome assembly; the gene is encoded in scaffold_836 (402 711 bp; Figure 1A ). CDS 184 , the second CDS, is located at 84 925 bp on the annotated reverse strand. From the phylogenetic analyses of all NRG1s ( Figure 1B , see Supplementary Figure S3) therefore the lizard type I N-CDS could probably be located outside the scaffold. In comparing the mRNA sequence of chicken NRG1-β1a (GenBank ® accession number L11264.1) with the genomic sequence, the cDNA coding for the first two amino acid residues methionine and tryptophan does not appear to be in the same CDS (see Supplementary Fig ure S11 at http://www.bioscirep.org/bsr/030/bsr0300267add.htm). Although a pentanucleotide sequence is located 948 bp upstream of CDS 76 and codes for methionine and tryptophan with correct splicing sites, the 5 -untranslated sequence does not match the chicken NRG1 mRNA. There are many regions with ambiguity upstream of the annotated sequence; the chicken gene may encode a novel type of NRG1 with extra CDS at the N-terminus and this needs to be further identified. Additionally, the type I N-CDSs of mammals and frog all contain a conserved NLS motif (see Supplementary Figure S1 ) except for chicken, suggesting that the annotated chicken NRG1 sequence (GenBank ® accession number AAA49037.1) might not be type I. Although the Danio N-CDS is lacking the NLS motif, it is conserved with basic amino acid residues. Furthermore, the presence of three predicted NLSs in mammalian type I NRG1s and at least two for most of the non-mammalian NRG1s imply the conservation of inward signalling.
Besides Danio, type II N-CDS of non-mammalian NRG1s could not be localized. These large and far upstream CDSs require more complete sequencing information to be determined. Neuron-specific type III NRG1s have been identified in all of the studied vertebrates and are encoded in relatively small genes (except for primate type VI). They have been known to be involved in nerve myelination [29] . Correspondingly, vertebrates with jaws and myelin sheathes of neurons are considered to be a defining characteristic of gnathostomates. The spacer of X. laevis nrg1 is overlap-encoded within type III N-CDS and the corresponding sequences are also identified in other non-mammalian genomes, suggesting the primitive possibility of type III isoforms and later evolution of the mammalian spacers. Drosophila Vn (Vein) protein [30] is an EGF-like protein involved in EGF receptor signalling in wing vein patterning. Although Vn protein, similarly to other vertebrate NRG proteins, contains Ig and EGF-like domains, it is a secreted molecule without a cytoplasmic domain and is more or less related to GGF2 (sNRG1) only. We checked the genes around the Vn locus and found no evidence of an . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 4
Type IV mammalian NRG1 N-CDS Peptides and DNA sequences of type IV NRG1 N-CDS and the neighbouring nucleotides of primates, horse, cow and rodents ( have not yet fully developed) were aligned. Compared with the majority of the sequences, bold residues indicate similar amino acids, lower-case residues are non-conserved residues and underlined residues are conserved in horse, cow and rodents. Bold lower-case residues and bold nucleotides can potentially be developed to form rodent type IV Nrg1. Nucleotide positions in the chromosome or contig are indicated.
Figure 5 All the known CDSs of NRG1 (types I-IV) CDS
132 is located at the 3 -end of the N-CDS of X. laevis type III nrg1 and the corresponding sequences can be identified from other non-mammalian genes. CDS 78 encoding the β4 domain can be identified only in rodent Nrg1s. CD, CDS; cyto. domain, cytoplasmic domain.
orthologue relationship between Vn and vertebrate NRG1; however, the possibility that both genes share a common ancestor or that NRG proteins actually evolved from Vn could not be ruled out.
Brain-specific type IV expressions are more restricted to mammals; however, rodents have not yet fully developed. A higher ratio of EQ (encephalization quotient) and faster evolution of neuronal genes [31] have been suggested in the literature. The EQ value of rodents is smaller than that of other mammals studied in this paper; it is interesting to find out whether the lower evolution rate delays the development of rodent type IV NRG1. Supplementary Table S3 (see http://www.bioscirep.org/ bsr/030/bsr0300267add.htm) shows that the higher calculated evolution rate in primates when compared with rodents is only suitable for the type I isoform. NRG1 is highly conserved with significant identity in vertebrates (see Supplementary Table S1) ; it is logical to assume that type I, II and III NRG1s are essential isoforms, whereas types IV, V and VI are not un-developed but probably cognitively related and lost in non-mammal or nonprimate genomes. In addition, human type IV brain-specific expression has been reported for a novel 128 bp exon E 128 (located 115 156 bp downstream of the first exon of type IV and 794 013 bp upstream of type I start codon) [15] , and an ATG in the downstream exon E 178 (Ig domain) acts as a translation initiation codon to initiate the translation of an N-terminally truncated NRG1 type IV protein lacking 22 amino acid residues. We used the sequence of E 128 to perform a BLAST analysis against all the studied genomes; there is no corresponding sequence that can be identified and no 22-amino-acid truncated mouse NRG1 has been annotated. In combination with Figure 4 , the promoter and RT-PCR studies showed no evidence to support the expression of rodent type IV Nrg1.
The stalk CDS 24 is the smallest exon in NRG1 and codes for an 8-amino-acid peptide (KHLGIEFM) to form the β1 variant; it contains the cleavage site (between residues phenylalanine and methionine by BACE1) for releasing active growth factor [22] . Three types of variations, namely short (α2 and β2 without stalks), medium [β1 or α1 (only in the frog sequence)] and Although it has been reported that BACE1-null mice are affected by remyelination of sciatic nerves [22] , the natural existence of isoform β2 (lack of cleavage domain) in vertebrates reveals the non-lethal character of the stalk. CDS 24 -deleted dominant-negative transgenic mice were generated by our group and analysed. They showed a schizophrenia-like phenotype in anatomical study and behaviour tests (results not shown). The phenotype might be produced because isoform β1 is involved in regulating the synaptic transmission or synchronization of cells in an activity-dependent manner [33] . The essential role played by the β1 variant could be the reason why CDS 24 , which escaped evolutionary mutation, has not been explored so far. Phosphorylation of membraneanchored proteins in the cytoplasmic domain has been demonstrated to be involved in the shedding of the ectodomains such as human meprinβ by PKC [34] and ACE (angiotensin-converting enzyme) by protein kinase CK2 [35] . PKC phosphorylation also attenuates proteolytic cleavage [36] ; moreover, NLS localization of DRAK2 (death-associated protein-kinase-related 2) is regulated by PKC [37] . There are 15 conserved phosphorylation sites predicted in the NRG1 cytoplasmic domain of most of the studied NRG1s (see Supplementary Figures S1 and S12 at http://www.bioscirep.org/bsr/030/bsr0300267add.htm). One of the putative PKC phosphorylation sites in the NLS conserved motif (KtKKQRKK) of the inner juxtamembrane may play essential roles in shedding, cleavage and signalling. Overall, multiple functional roles of NRG1 played by different isoforms are presumably conserved in all vertebrates; however, spacer evolution is the major difference between mammals and other vertebrates. Moreover, b-and c-tails can only be identified in mammal and amphibian genes. The evolution of NRG1 N-CDS is therefore observed to be ongoing ( Figure 6 ). , and E 290(VI) are referenced from Talmage [1] . The convex surface represents an excess nucleotide for the match with the concave surface (an additional nucleotide is required for a codon) to form frameshift mutations after two CDSs are joined; the flat surface represents a full codon at the ends of the CDS. Possible alternative splicing NRG1 isoforms and GenBank ® accession numbers of corresponding sequences are listed. UI indicates non-existing isoforms because there is a lack of supporting sequence data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Figure S13
Peptide and cDNA sequences of all studied NRG1s Cyto. domain, cytoplasmic domain.
